ÂÜÀòÂÒÂ×

Dr. Michelle Boytim is CPP’s Program Manager, Clinical Research, and performs operations management for all of the clinical trials in the Company’s development portfolio. She is actively involved in the oversight of the clinical sites and service providers, including data management, contract monitoring, and safety surveillance. Dr. Boytim has more than 10 years of experience in clinical research programs for pharmaceutical, and medical device companies and has been a clinical research manager at several small start-up companies in both the pharmaceutical and medical device arenas. Most recently she gained experience in companion diagnostics for oncology products at Ventana Medical Systems.

Previously, she was the Manager, of Clinical Research for AmpliMed Corporation, an Oncology Drug Development company. At AmpliMed Dr. Boytim was project manager for six multi-center clinical trials in the U.S. and was responsible for the coordination of two data monitoring committees. She developed and maintained a clinical trial management system for two drug development programs encompassing eight clinical trials.

Dr. Boytim collaborated with investigators to analyze data and prepare numerous abstracts, presentations, and manuscripts. She was actively involved in protocol development and wrote four phase 1 clinical study reports and collaborated on the writing of phase 2 clinical study reports for submission to the FDA. Her areas of expertise include data analysis, scientific writing, protocol development, manuscripts, clinical study reports, and the creation of customized clinical trial management systems. Dr. Boytim earned her B.S. degree in Microbiology and Immunology from the University of Miami, and her Ph.D. in Immunology from Stanford University.